Shenzhen Mindray Bio-Medical Electronics Co Ltd 2021 SR
The report highlights Mindray's 30th anniversary and its customized sustainability strategy focused on six major areas, including green development and social responsibility. In 2021, the company invested 2.726 billion RMB in R&D and achieved a BBB MSCI ESG rating. Key environmental milestones included a 52% reduction in hazardous waste outbound shipments and the establishment of China's first 5G ICU. Mindray also expanded its social impact through the "Hundred Cities Action" for standardized laboratories and significant medical device donations to regions like Henan and Africa.
Company: Shenzhen Mindray Bio-Medical Electronics Co Ltd
Sector: Health Care
Country: China
Year: 2021
Type: SR
Pages: 65
Shenzhen Mindray Bio-Medical Electronics Co Ltd
Sustainability Report
The report highlights Mindray's 30th anniversary and its customized sustainability strategy focused on six major areas, including green development and social responsibility. In 2021, the company invested 2.726 billion RMB in R&D and achieved a BBB MSCI ESG rating. Key environmental milestones included a 52% reduction in hazardous waste outbound shipments and the establishment of China's first 5G ICU. Mindray also expanded its social impact through the "Hundred Cities Action" for standardized laboratories and significant medical device donations to regions like Henan and Africa.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jan 1, 2021 - Dec 31, 2021
Fiscal Year
2021
Published
Apr 18, 2022
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees